We provide 3rd party tested peptides in many different options for your research purposes only
FDA DISCLAIMER
The information provided on this website has not been evaluated by the U.S. Food and Drug Administration (FDA). None of the statements herein, nor any of the products offered, are intended to diagnose, treat, cure, or prevent any medical condition.
All products are supplied strictly as laboratory research reagents and are not
FDA DISCLAIMER
The information provided on this website has not been evaluated by the U.S. Food and Drug Administration (FDA). None of the statements herein, nor any of the products offered, are intended to diagnose, treat, cure, or prevent any medical condition.
All products are supplied strictly as laboratory research reagents and are not for human consumption. We do not provide products to patients and do not make any claims regarding medical use.
Pikes Peak Peppers operates solely as a chemical supplier. It is not a compounding pharmacy and does not operate as a compounding facility under Section 503A of the Federal Food, Drug, and Cosmetic Act.
CP-3 RT 10 mg is a research-grade synthetic peptide reagent that functions as a triple-agonist at GIP, incretin, and glucagon receptor subtypes. This first-in-class multi-receptor agonist peptide has emerged as one of the most significant research tools in contemporary metabolic
signaling studies, owing to its unprecedented ability to engage three distinct G protein-coupled receptors through a single molecular entity.
CP-2 TZ 30 mg offers researchers a mid-scale quantity of this advanced dual-receptor agonist peptide, enabling comprehensive dose-response evaluations and extended experimental timelines in metabolic signaling research. The 30 mg format is especially valued by laboratories conducting systematic receptor pharmacology studies, as it provides sufficient material for constructing complete concentration-effect curves across multiple cell lines and assay platforms without reagent supply interruptions.
TB-500 and BPC-157 Combination at 20 mg total peptide content provides an expanded quantity of this dual-peptide research formulation, designed for investigators conducting comprehensive, replicate-intensive studies that explore the combined effects of thymosin beta-4 fragment and Body Protection Compound-157 on cellular processes.
Add a footnote if this applies to your business
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.